Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
Immediate attention should be paid to concomitant medications at diagnosis because they may have impact on the initial course of IBD.
Authors
- Hiromu Morikubo (ORCID: https://orcid.org/0000-0002-1232-5879)
- Hajime Yamazaki (ORCID: https://orcid.org/0000-0002-9034-4370)
- Takayoshi Nagahama
- Katsuhiko Nagai (ORCID: https://orcid.org/0000-0001-8900-6019)
- Taku Kobayashi (ORCID: https://orcid.org/0000-0002-2073-4234)
Institutions
- Kyoto University (JP)
- Kitasato Institute Hospital (JP)
- Kitasato University (JP)
Publication Details
- Journal
- Inflammatory Intestinal Diseases
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1159/000541984
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00